Form 4: Bankwell EVP Chivily Reports Stock Grants, Tax-Related Sale

Bankwell Financial Group's EVP & Chief Credit Officer, Christine Chivily, reported recent stock grants and a sale of shares to cover tax liabilities.

Summary

• Christine Chivily, EVP & Chief Credit Officer, reported transactions on February 9, 2026.
• Acquired 2,054 shares of common stock as a grant under the 2022 Bankwell Financial Group, Inc. Stock Plan.
• These 2,054 shares consist of 1,057 restricted stock vesting in three equal annual installments starting February 7, 2027, and 1,057 performance restricted stock with a three-year cliff vesting on February 7, 2029, contingent on performance goals.
• Acquired an additional 581 shares of common stock, which were granted and vested on February 9, 2026, related to 2023, 2024, and 2025 additional performance shares.
• Disposed of 1,985 shares of common stock at an average price of $49.80 (ranging from $49.38 to $50.15) through a cashless stock exercise program.
• This disposition covered the tax liability for the vesting of a total of 4,232 shares.
• Following these transactions, Chivily's direct beneficial ownership of common stock is 16,186 shares.
• Other grants mentioned include 4,894 shares (2,447 restricted vesting from February 7, 2025, 2,447 performance restricted), 490 performance restricted shares vesting February 7, 2027, and 1,470 shares (735 restricted vesting from February 7, 2026, 735 performance restricted vesting February 7, 2028), of which 245 shares have vested.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting ongoing executive compensation through equity grants and the routine management of tax obligations associated with vested shares. The grants align executive interests with long-term company performance.

Positives

• Receipt of 2,054 shares of common stock as a grant, indicating ongoing equity compensation.
• Acquisition of 581 vested performance shares, reflecting achievement of past performance goals.
• Additional significant stock grants mentioned in the footnotes (4,894 shares, 490 shares, 1,470 shares) demonstrate continued long-term incentive alignment.

Negatives

• Disposition of 1,985 shares of common stock, reducing direct beneficial ownership, although this was for tax purposes.

Future Outlook

The filing indicates future vesting schedules for various restricted and performance-based stock grants, with vesting dates extending to February 7, 2029, contingent on continued employment and performance goal achievement.

Industry Context

StockSavvy.ai notes that equity compensation, including restricted stock and performance shares, is a standard practice in the financial services industry to align executive incentives with shareholder interests and promote long-term retention. The tax-related sale is a common occurrence for executives receiving such compensation.

Related Party Transactions

• Grant of 2,054 shares of common stock under the 2022 Bankwell Financial Group, Inc. Stock Plan.
• Grant of 581 shares of common stock as vested performance shares.
• Sale of 1,985 shares of common stock through the Company sponsored cashless stock exercise program to cover tax liability.
• Grants of 4,894, 490, and 1,470 shares of common stock under the 2022 Bankwell Financial Group, Inc. Stock Plan.

Stakeholder Impact

• Shareholders: The grants align executive incentives with shareholder value creation over the long term. The tax-related sale is a routine event and does not indicate a lack of confidence.
• Employees: The equity compensation structure reflects the company's approach to rewarding and retaining key executives.

Next Steps

• Future vesting of 1,057 restricted shares in three equal annual installments starting February 7, 2027.
• Potential vesting of 1,057 performance restricted shares on February 7, 2029, subject to performance goals.
• Future vesting of 2,447 restricted shares in three equal annual installments starting February 7, 2025.
• Potential vesting of 2,447 performance restricted shares.
• Potential vesting of 490 performance restricted shares on February 7, 2027, subject to performance goals.
• Future vesting of 735 restricted shares in three equal annual installments starting February 7, 2026.
• Potential vesting of 735 performance restricted shares on February 7, 2028, subject to performance goals.

Key Dates

Recommendation

The filing details routine insider transactions involving equity compensation grants and a sale to cover tax liabilities. These are standard events for executives and do not provide new information that would significantly alter the investment thesis for Bankwell Financial Group. The grants demonstrate continued alignment of executive interests with the company's long-term performance, supporting a 'hold' recommendation.

Keywords

Bankwell Financial Group, BWFG, Christine Chivily, Insider Transaction, Form 4, Stock Grant, Restricted Stock, Performance Shares, Equity Compensation, Tax Liability Sale